Pinkerton Retirement Specialists, LLC Gilead Sciences, Inc. Transaction History

Pinkerton Retirement Specialists, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $71,525 - $81,584	-941 Reduced 20.01%	3,762 $289,000
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $9,972 - $11,362	129 Added 2.82%	4,703 $390,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $285,051 - $409,235	4,574 New	4,574 $392,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $21,852 - $26,640	-300 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$71.15 - $83.52 $21,345 - $25,056	300	300 $22,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Pinkerton Retirement Specialists, LLC, based on Form 13F filings with the SEC.

Stay updated on Pinkerton Retirement Specialists, LLC with notifications on news.